Corporate News     29-Jul-22
Alembic Pharmaceuticals receives USFDA approval for Diclofenac Sodium Topical Gel, 3%
Used for topical treatment of actinic keratoses
Alembic Pharmaceuticals today announced that its wholly owned subsidiary, Aleor Dermaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diclofenac Sodium Topical Gel, 3%.The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Solaraze Topical Gel, 3%, of fougera Pharmaceuticals Inc. (Fougera).

Diclofenac Sodium Topical Gel, 3% is indicated for the topical treatment of actinic keratoses. Sun avoidance is indicated during therapy. Diclofenac Sodium Topical Gel, 3% has an estimated market size of. US$10 million for twelve months ending Mar., 2022 according to IQVIA.

Previous News
  Alembic Pharmaceuticals consolidated net profit declines 29.03% in the December 2022 quarter
 ( Results - Announcements 01-Feb-23   17:10 )
  Alembic receives USFDA approval for Fesoterodine Fumarate ER Tablets
 ( Corporate News - 06-Jan-23   11:03 )
  Alembic Pharmaceuticals receives USFDA approval for Diclofenac Sodium Topical Gel, 3%
 ( Corporate News - 29-Jul-22   10:43 )
  CRISIL reaffirms ratings of Alembic Pharmaceuticals with 'stable' outlook
 ( Hot Pursuit - 08-Mar-24   11:22 )
  Alembic Pharma gets USFDA final approval for Fesoterodine Fumarate
 ( Hot Pursuit - 06-Jan-23   10:59 )
  Alembic Pharma gets USFDA nod for Icatibant injection
 ( Hot Pursuit - 17-Jun-24   14:03 )
  Alembic Pharmaceuticals to discuss results
 ( Corporate News - 17-Oct-23   10:13 )
  Alembic Pharmaceuticals consolidated net profit declines 49.22% in the September 2021 quarter
 ( Results - Announcements 10-Nov-21   15:38 )
  Alembic Pharma gets USFDA final approval for Prazosin Hydrochloride capsules
 ( Hot Pursuit - 08-Mar-23   09:19 )
  Alembic Pharmaceuticals receives USFDA final approval for Arformoterol Tartrate Inhalation Solution
 ( Corporate News - 11-May-22   11:39 )
  Alembic Pharmaceuticals receives USFDA approval for Prazosin Hydrochloride Capsules
 ( Corporate News - 08-Mar-23   09:14 )
Other Stories
  John Cockerill India to declare Quarterly Result
  08-Jul-24   14:58
  Kumbhat Financial Services to conduct board meeting
  08-Jul-24   14:58
  D-Link (India) announces board meeting date
  08-Jul-24   14:58
  AAVAS Financiers to hold AGM
  08-Jul-24   13:47
  Pudumjee Paper Products to hold AGM
  08-Jul-24   13:47
  Hemadri Cements AGM scheduled
  08-Jul-24   13:47
  Vertoz Advertising AGM scheduled
  08-Jul-24   13:47
  Menon Bearings to announce Quarterly Result
  08-Jul-24   13:37
  K&R Rail Engg. to discuss results
  08-Jul-24   13:37
  Rajoo Engineers to declare Quarterly Result
  08-Jul-24   13:37
Back Top